Mar 16, 2016 11:00 am UTC| Business
EWING, N.J., March 16, 2016 -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced 12 week efficacy and 52 week safety results from the phase 3 clinical study (QST-13-003) evaluating testosterone enanthate administered...
Mar 16, 2016 11:00 am UTC| Business
Trial marks the final clinical milestone on the pathway to pursue a broaderFeraheme®label WALTHAM, Mass., March 16, 2016 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that it has enrolled the first...
Capnia Announces Exclusive Distribution Agreement for Sale of CoSense® in China
Mar 16, 2016 11:00 am UTC| Business
REDWOOD CITY, Calif., March 16, 2016 -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops and commercializes innovative diagnostics, devices and therapeutics addressing unmet medical needs,...
DNA Brands and Accel Brands Sign Joint Venture Agreement
Mar 16, 2016 11:00 am UTC| Business
Fort Lauderdale FL, March 16, 2016 -- DNA Brands Inc. (OTC PINK: DNAX) , the owner of DNA Energy Drink and Accel Brands Inc. aka Accelpath, Inc (OTC Pink: (ACLP), are happy to announce that the two companies...
Mar 16, 2016 11:00 am UTC| Business
MIGDAL HAEMEK, Israel and TONAMI, Japan, March 16, 2016 -- TowerJazz, the global specialty foundry leader, announced today it will participate at APEC (the Applied Power Electronics Conference) on March 21-23, 2016 in...
Mar 16, 2016 11:00 am UTC| Business
- Results to be presented on March 17th at ECCO 2016 in Amsterdam - Nanocort is a novel i.v. targeted pegylated liposomal prednisolone product - Clear benefit shown in 70% of the patients with 2 administrations - 7...
II-VI Incorporated Completes its Acquisition of ANADIGICS, Inc.; Updates its Outlook for Q3 FY 16
Mar 16, 2016 10:55 am UTC| Business
PITTSBURGH, March 16, 2016 -- II-VI Incorporated (Nasdaq:IIVI), a leader in engineered materials and optoelectronic components, announced today that it has successfully completed its acquisition of ANADIGICS, Inc....